RxDoctor Payments Data

Jonathan Buchanan, MD

Family Medicine · Carthage, MSNPI 1073925244

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 63 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$238
  • AstraZeneca$182
  • GSK$133
  • AbbVie$107
  • Abbott$103
  • Bayer$45
  • plus $251 from 10 others

What the payments were for

  • Food & beverage$1,04398%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$18,924
Medicare patients
128
Services billed
238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide201$196,291
JardianceEmpagliflozin67$65,116
EliquisApixaban74$61,445
LinzessLinaclotide77$43,656
FarxigaDapagliflozin Propanediol46$39,022
Tresiba Flextouch U-200Insulin Degludec42$27,723
RybelsusSemaglutide22$27,137
MounjaroTirzepatide18$21,969
JanuviaSitagliptin Phosphate29$21,411
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$21,364
EntrestoSacubitril/Valsartan17$20,661
XareltoRivaroxaban18$16,728
TrulicityDulaglutide14$13,680
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen412$10,807
SymbicortBudesonide/Formoterol Fumarate44$10,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$238$223,428223 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$182$55,966101 claims
AbbVieLinzess$107$43,65677 claims
Lilly USA, LLCMounjaro, Trulicity$28$35,64932 claims
GSKTrelegy Ellipta, Breo Ellipta$133$28,23046 claims
MerckJanuvia$17$21,41129 claims
NovartisEntresto$33$20,66117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Carthage

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →